Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820308 · ClinicalTrials.gov registry record · NA
Companion Dog Walking for ICU Survivor Health
A NA study of Depression and Anxiety, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT05820308: Completed NA study of Depression and Anxiety, sponsored by University of Missouri, Kansas City.
NCT05820308 is a NA study of Depression and Anxiety that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 6 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820308, a NA study of Depression and Anxiety, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors. The main question\[s\] it aims to answer are: * What is the feasibility of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors. * What is the acceptability of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors. The secondary question\[s\] it aims to answer are: \- What are the differences in depression, anxiety, serum cortisol, and quality of life between and within a companion dog walking intervention compared to an attention control education intervention for ICU survivors? Participants in the intervention group will be asked to: * Participate in dog walking with their pet dog at least three times per week, for at least 10 minutes each walk, for 8-weeks. * Wear an activity monitor and record their dog walks in a diary. * Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8. * Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8. Participants in the control group will be asked to: * Read educational materials about their pet dog's health once every week (education materials are provided by the researchers). * Wear an activity monitor and record when they read their education materials in a diary. * Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8. * Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8. Participants will be assigned to an intervention
Primary Outcome
Data will be collected to answer the following questions: 1. To what extent does the recruitment procedure produce study participants? 2. How many participants met inclusion and exclusion criteria? 3. What are the obstacles to recruitment? 4. What was the attrition rate of participants? 5. To what extent was fidelity of the intervention maintained by participants? 6. To what extent were measurements completed? 7. What was the extent and patterns of missing data?
Conditions Studied
Interventions
- BEHAVIORAL Attention Control Group
- BEHAVIORAL Companion Dog Walking
Study Locations (2)
Colorado
- Penrose Hospital - Colorado Springs
- St. Francis Hospital - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
What the finished NCT05820308 record still lists
NCT05820308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Attention Control Group is the first listed.
NCT05820308 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05820308 about?
NCT05820308 is a clinical study titled "Companion Dog Walking for ICU Survivor Health". The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors. The main question\[s\] it aims to answer are: * What is...
What is the current status of trial NCT05820308?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-05-15. Estimated completion is 2024-05-01.
What conditions does trial NCT05820308 study?
This clinical trial studies the following conditions: Depression, Anxiety, Quality of Life, Post-Intensive Care Syndrome.
What interventions are being tested in trial NCT05820308?
The interventions under investigation include: Attention Control Group (BEHAVIORAL), Companion Dog Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT05820308?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05820308 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05820308's enrollment target sits among peer trials
6 672nd of 679 higher than 7 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy